PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
25998443-5	2015	METHODS: The effect of ambroxol and/or beclomethasone dipropionate on IL-8, RANTES and iNOS levels was assessed by Western blot analysis; IL-8, MPO and 3-NT levels were measured by ELISA.	Beclomethasone	39-66	C-X-C motif chemokine ligand 8	Homo sapiens	70-74	
25998443-9	2015	Beclomethasone dipropionate had no effect on RANTES but halved iNOS expression and IL-8 release.	Beclomethasone	0-27	C-X-C motif chemokine ligand 8	Homo sapiens	83-87	
25998443-11	2015	Ambroxol and beclomethasone dipropionate inhibited LPS-stimulated IL-8, MPO and 3-NT release (p < 0.05).	Beclomethasone	13-40	C-X-C motif chemokine ligand 8	Homo sapiens	66-70	
25998443-12	2015	Ambroxol/beclomethasone dipropionate combination potentiated the inhibition of IL-8 and 3-NT production in BEAS-2B with PMNs (p < 0.05 and p < 0.01, respectively).	Beclomethasone	9-36	C-X-C motif chemokine ligand 8	Homo sapiens	79-89	
25998443-14	2015	CONCLUSION: The additive effect of ambroxol and beclomethasone dipropionate on IL-8 and 3-NT inhibition suggests new therapeutic options in the treatment of neutrophil-related respiratory diseases such as chronic obstructive pulmonary disease and respiratory infections.	Beclomethasone	48-75	C-X-C motif chemokine ligand 8	Homo sapiens	79-89	
14643170-5	2004	Pre-treatment with beclomethasone, budesonide or fluticasone reduced TNFalpha- and IL-1beta-stimulated IL-8 and RANTES release from HASMC in a dose dependent manner.	Beclomethasone	19-33	C-X-C motif chemokine ligand 8	Homo sapiens	103-107	
15679717-4	2005	RESULTS: The release of GM-CSF, RANTES and IL-8 in ISC was significantly reduced by BDP plus salbutamol or formoterol as compared with either drug alone (P < 0.0001).	Beclomethasone	84-87	C-X-C motif chemokine ligand 8	Homo sapiens	43-47	
14643170-8	2004	The results suggest that the topical steroids fluticasone, budesonide and to a lesser extent beclomethasone may have beneficial effects on airway inflammation in asthma by reducing RANTES and IL-8-induced leukocyte infiltration into the airway wall.	Beclomethasone	93-107	C-X-C motif chemokine ligand 8	Homo sapiens	192-196	
14643170-2	2004	This study was performed to investigate the effectiveness of the commonly used steroids beclomethasone, budesonide and fluticasone in downregulating HASMC production of RANTES and IL-8.	Beclomethasone	88-102	C-X-C motif chemokine ligand 8	Homo sapiens	180-184	
7798535-7	1994	Treatment with inhaled beclomethasone dipropionate 500 micrograms twice a day led to a significant decrease in both the expression of GM-CSF (p < 0.01) and IL-8 (p < 0.02) and the number of EG2-staining cells (p < 0.01) in the epithelium.	Beclomethasone	23-50	C-X-C motif chemokine ligand 8	Homo sapiens	159-163	
7542097-0	1995	Expression of granulocyte/macrophage-colony-stimulating factor, interleukin-8 and RANTES in the bronchial epithelium of mild asthmatics is down-regulated by inhaled beclomethasone dipropionate.	Beclomethasone	165-192	C-X-C motif chemokine ligand 8	Homo sapiens	64-77	
11015126-0	2000	Effects of early inhaled beclomethasone therapy on tracheal aspirate inflammatory mediators IL-8 and IL-1ra in ventilated preterm infants at risk for bronchopulmonary dysplasia.	Beclomethasone	25-39	C-X-C motif chemokine ligand 8	Homo sapiens	92-96	
11015126-7	2000	Median IL-8 levels were lower in beclomethasone versus placebo infants on study days 8 (82.9 vs. 209.2, P < 0.01) and 15 (37.4 vs. 77.4, P < 0.03) after controlling for antenatal glucocorticoid therapy and maternal race.	Beclomethasone	33-47	C-X-C motif chemokine ligand 8	Homo sapiens	7-11	
11015126-9	2000	Fewer beclomethasone infants with baseline IL-8 levels in the interquartile range required systemic glucocorticoid therapy (beclomethasone 30.6% vs. placebo 65.8%, P < 0.01) or developed BPD (beclomethasone 42.4% vs. placebo 69.4%, P < 0.03).	Beclomethasone	6-20	C-X-C motif chemokine ligand 8	Homo sapiens	43-47	
11015126-11	2000	Beclomethasone-treated infants with moderately elevated baseline IL-8 levels received less subsequent systemic glucocorticoid therapy and had a lower incidence of BPD than nontreated infants.	Beclomethasone	0-14	C-X-C motif chemokine ligand 8	Homo sapiens	65-69	
7798535-10	1994	Also, beclomethasone dipropionate may inhibit eosinophil activation partly by downregulating the expression of GM-CSF and IL-8 in the bronchial epithelium.	Beclomethasone	6-33	C-X-C motif chemokine ligand 8	Homo sapiens	122-126